Previous studies suggest that cyclooxygenase-2 (COX-2) expression may predict survival
among patients with non-small cell lung cancer. COX-2 may interact with epidermal growth …

Cyclooxygenase (Cox)-2 plays an important role in cell proliferation, carcinogenesis and
tumor growth, in part through the synthesis of prostaglandin E2 (PGE2) as well as through …

Context.—Previous studies report that increased expression of cyclooxygenase 2 (COX-2)
correlates with poor clinical outcome in several malignancies, including non–small cell lung …

Recently, we demonstrated that elevated expression of cyclooxygenase 2 (COX-2) is
frequently seen in a specific type of lung cancer, ie, adenocarcinoma, and is possibly …

Both cyclooxygenase (COX)-2 and epidermal growth factor receptor (EGFR) are thought to
play important roles in the pathogenesis of non-small cell lung cancer (NSCLC). A number …

Abstract Cyclooxygenase-2 (COX-2), the enzyme that converts arachidonic acid to
prostaglandins, is overexpressed in a variety of different tumors, including those of the colon …

Abstract Cyclooxygenase-2 (COX-2) is overexpressed in lung cancer, especially in
adenocarcinoma (ADC). Our aim was to determine the prognostic value of COX-2 on …

BACKGROUND: We investigated the prognostic value of cyclooxygenase-2 (COX-2) for
survival of patients with non-small cell lung cancer (NSCLC). METHODS: We performed a …

Background To evaluate the expression of EGFR and COX-2 and their correlation with
prognosis in NSCLC Methods The paraffin embedded tumor samples of 50 NSCLC patients …

Cyclooxygenase (COX)-2 is implicated in the oncogenesis of many cancers, and COX-2
inhibitors are effective in preventing the development of tumours, such as in colon cancer. Its …